Objective: Pathologic changes in varicella-zoster virus (VZV)-infected arteries include inflammation, thickened intima, and paucity of smooth muscle cells. Since no criteria have been established for early vs late VZV vasculopathy, we examined inflammatory cells and their distribution in 6 normal arteries, and 2 VZV-infected arteries 3 days after onset of disease (early) and 10 months after protracted neurologic disease (late).Methods: VZV-infected temporal artery obtained 3 days after onset of ischemic optic neuropathy from an 80-year-old man, VZV-infected middle cerebral artery (MCA) obtained 10 months after protracted disease from a 73-year-old man, and 5 MCAs and 1 temporal artery from normal subjects, age 22-60 years, were examined histologically and immunohistochemically using antibodies against VZV and inflammatory cell subsets.
Results:In both early and late VZV vasculopathy, T cells, activated macrophages, and rare B cells were found in adventitia and intima. In adventitia of early VZV vasculopathy, neutrophils and VZV antigen were abundant and a thickened intima was associated with inflammatory cells in vaso vasorum vessels. In media of late VZV vasculopathy, viral antigen, but not leukocytes, was found. VZV was not seen in inflammatory cells. Inflammatory cells were absent in control arteries. In varicella-zoster virus (VZV) vasculopathy, virus-infected regions are associated with a thickened intima composed of myofibroblasts, a paucity of smooth muscle cells in media, and disruption of internal elastic lamina.1 Similar morphologic changes have been found in other vascular diseases, such as pulmonary arterial hypertension (PAH) and atherosclerosis, 2 in which inflammation has emerged as a pathogenic component. For example, in PAH, inflammatory cells surrounding pulmonary artery lesions secrete CX3CL1, which induces vascular smooth muscle cell (VSMC) proliferation.3 In atherosclerosis, activated macrophages, in addition to other cells, secrete platelet-derived growth factor-BB and insulin-like growth factor-I, which promote VSMC migration 4 ; interleukin-1B also promotes VSMC proliferation. 5,6 We hypothesize that 1) after reactivation from trigeminal ganglia, virus spreads transaxonally to infect the adventitia, followed by transmural migration to the media 1,7 ; 2) inflammatory cells are recruited to virus-infected sites; and 3) inflammatory cells secrete factors that contribute to vessel wall changes seen in VZV vasculopathy. Characterization of immune cells involved in VZV vasculopathy could elucidate mechanisms of VZV-induced vascular remodeling and identify potential targets for therapy.